The benchmark indices rebounded 0.4 percent on August 25 after nearly a percent loss in the previous session, but the market breadth remained weak. About 1,493 shares declined compared to 1,298 advancing shares on the NSE. The market is likely to consolidate further until it decisively gets back above last Thursday's high. Below are some short-term trading ideas to consider:Mehul Kothari, AVP - Te...

Bulls continued to hold the fort despite pressure from bears, helping the Nifty 50 close 0.13 percent higher on August 21, while the market breadth was nearly balanced. Around 1,381 shares declined compared to 1,350 advancing shares on the NSE. Overall, the trend remains favourable for bulls, despite the likelihood of intermittent consolidation. Below are some short-term trading ideas to consider:...

Equity benchmarks started off the monthly F&O expiry week on a negative note, with the Nifty 50 declining 0.63 percent, extending its downward journey for the third straight session on July 28. The market breadth continued to be dominated by bears, with 2,043 shares declining compared to 673 advancing on the NSE. The market may continue to consolidate with a negative bias in the upcoming sessions....

The benchmark indices extended their downward move for the second consecutive session, falling 0.9 percent on July 25, with market breadth largely favouring the bears. A total of 2,179 shares were under pressure, compared to just 475 advancing shares on the NSE. The market is expected to consolidate further as long as the frontline indices continue trading below their medium-term moving averages. ...

Although Trump's pharma sector tariffs are threatening to hit the sector, and different estimates of the possible impact, analysts across brokerages are keeping their expectations steady for earnings following estimations of muted Q4 FY2025 performance. Estimates reveal a subtle revenue growth, margin improvement and strong US generics performance to support earnings beyond a muted Q4 FY2025 perfo...